Olympus Co. (OTCMKTS:OLYMY – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 6,721 shares, an increase of 768.3% from the August 15th total of 774 shares. Based on an average daily volume of 49,485 shares, the days-to-cover ratio is presently 0.1 days.
Olympus Stock Down 1.3%
OLYMY stock opened at $12.29 on Friday. Olympus has a 12-month low of $8.08 and a 12-month high of $13.73. The stock’s 50 day simple moving average is $12.09 and its 200 day simple moving average is $10.76.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group downgraded Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.
About Olympus
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Featured Stories
- Five stocks we like better than Olympus
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
